Miguel Angel Campanero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Miguel Angel Campanero has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- José Ramón Azanza
Clinica Universidad de Navarra, Spain
5 shared publications Belén Sádaba
Clínica Universitaria de Navarra, Universidad de Navarra
4 shared publicationsJose Ramón Azanza
Clinical Investigation Unit, University Hospital, University of Navarra, C/Pio XII s/n., 31080 Pamplona, Navarra, Spain
3 shared publicationsB. Calahorra
Department of Clinical Pharmacology, Clinica Universitaria de Navarra, Pamplona, Spain
2 shared publicationsB. Sádaba
Department of Clinical Pharmacology, Clinica Universitaria de Navarra, Pamplona, Spain
2 shared publicationsEmilio García Quetglas
Clínica Universitaria de Navarra, Universidad de Navarra
2 shared publications
Latest Publications
- 1 March 2010
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 51 (4) , 875-881
Simultaneous determination of diosmin and diosmetin in human plasma by ion trap liquid chromatography–atmospheric pressure chemical ionization tandem mass spectrometry: Application to a clinical pharmacokinetic study
- 1 March 2010
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 51 (4) , 875-881
Simultaneous determination of diosmin and diosmetin in human plasma by ion trap liquid chromatography–atmospheric pressure chemical ionization tandem mass spectrometry: Application to a clinical pharmacokinetic study
- 1 January 2008
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 28 (3) , 139-147
Pharmacokinetic and Pharmacodynamic Modelling of Arterial Haemodynamic Effects of Terazosin in Healthy Volunteers
This study aimed to investigate, in healthy volunteers, the relationship between the plasma concentrations of the α1-adrenoceptor antagonist terazosin and its effects on arterial blood pressure after a single oral administration of terazosin 2 mg.
- 1 January 2008
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 28 (3) , 139-147
Pharmacokinetic and Pharmacodynamic Modelling of Arterial Haemodynamic Effects of Terazosin in Healthy Volunteers
This study aimed to investigate, in healthy volunteers, the relationship between the plasma concentrations of the α1-adrenoceptor antagonist terazosin and its effects on arterial blood pressure after a single oral administration of terazosin 2 mg.
- 24 October 2006
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 28 (1) , 19-33
Stereoselective pharmacokinetic analysis of tramadol and its main phase I metabolites in healthy subjects after intravenous and oral administration of racemic tramadol
The kinetics of tramadol enantiomers are stereoselective when doses of the racemic drug are given orally. To document whether the route of administration determines thestereoselectivekinetics of tramadol enantiomers, healthy volunteers received 100 mg oral or intravenous doses of racemic tramadol, and serial blood samples were obtained to assay tramadol enantiomers and their main phase I metabolites,O‐demethyltramadol andN‐demethyltramadol. To assess accurately the involvement of their metabolites in the pharmacokinetics of tramadol, it is essential to determine the rate and extent of the formation of the enantiomers of these metabolites. A simultaneous pharmacokinetic model describing the plasma concentration‐curves of the generated metabolites and the parent compounds after intravenous and oral drug administration is developed and presented. Tramadol andO‐demethyltramadol were the major compounds detected in plasma after intravenous administration. Nevertheless, theN‐demethylation of tramadol showed a significant increase when the oral route was used. After both oral and intravenous doses, the kinetics of the tramadol enantiomers were stereoselective. TheAUCfor (R)‐(+)‐tramadol was greater than theAUCfor (S)‐(−)‐tramadol. The formation ofN‐demethyltramadol also was enantioselective after oral administration of racemic tramadol, with a greaterAUCfor (R)‐(+)‐N‐demethyltramadol than for (S)‐(−)‐N‐demethyltramadol. In the opposite form, (S)‐(−)‐O‐demethyltramadol was formed faster than (R)‐(+)‐O‐demethyltramadol. The metabolism of tramadol was also route‐dependent with a different enantiomeric ratio for tramadol and its main phase I metabolites after intravenous and oral administration. The disposition ofN‐demethyltramadol was concentration‐dependent. Copyright © 2006 John Wiley & Sons, Ltd.
- 24 October 2006
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 28 (1) , 19-33
Stereoselective pharmacokinetic analysis of tramadol and its main phase I metabolites in healthy subjects after intravenous and oral administration of racemic tramadol
The kinetics of tramadol enantiomers are stereoselective when doses of the racemic drug are given orally. To document whether the route of administration determines thestereoselectivekinetics of tramadol enantiomers, healthy volunteers received 100 mg oral or intravenous doses of racemic tramadol, and serial blood samples were obtained to assay tramadol enantiomers and their main phase I metabolites,O‐demethyltramadol andN‐demethyltramadol. To assess accurately the involvement of their metabolites in the pharmacokinetics of tramadol, it is essential to determine the rate and extent of the formation of the enantiomers of these metabolites. A simultaneous pharmacokinetic model describing the plasma concentration‐curves of the generated metabolites and the parent compounds after intravenous and oral drug administration is developed and presented. Tramadol andO‐demethyltramadol were the major compounds detected in plasma after intravenous administration. Nevertheless, theN‐demethylation of tramadol showed a significant increase when the oral route was used. After both oral and intravenous doses, the kinetics of the tramadol enantiomers were stereoselective. TheAUCfor (R)‐(+)‐tramadol was greater than theAUCfor (S)‐(−)‐tramadol. The formation ofN‐demethyltramadol also was enantioselective after oral administration of racemic tramadol, with a greaterAUCfor (R)‐(+)‐N‐demethyltramadol than for (S)‐(−)‐N‐demethyltramadol. In the opposite form, (S)‐(−)‐O‐demethyltramadol was formed faster than (R)‐(+)‐O‐demethyltramadol. The metabolism of tramadol was also route‐dependent with a different enantiomeric ratio for tramadol and its main phase I metabolites after intravenous and oral administration. The disposition ofN‐demethyltramadol was concentration‐dependent. Copyright © 2006 John Wiley & Sons, Ltd.
- 26 March 2004
- Published by Elsevier in Journal of Chromatography A
- Vol. 1031 (1-2) , 265-273
Therapeutic drug monitoring for sirolimus in whole blood of organ transplants by high-performance liquid chromatography with ultraviolet detection
- 26 March 2004
- Published by Elsevier in Journal of Chromatography A
- Vol. 1031 (1-2) , 265-273
Therapeutic drug monitoring for sirolimus in whole blood of organ transplants by high-performance liquid chromatography with ultraviolet detection
- 17 December 2003
- Published by Elsevier in Journal of Chromatography A
- Vol. 1031 (1-2) , 219-228
Simultaneous stereoselective analysis of tramadol and its primary phase I metabolites in plasma by liquid chromatography
- 17 December 2003
- Published by Elsevier in Journal of Chromatography A
- Vol. 1031 (1-2) , 219-228
Simultaneous stereoselective analysis of tramadol and its primary phase I metabolites in plasma by liquid chromatography
- 12 December 2001
- Published by Wiley in Biomedical Chromatography
- Vol. 16 (1) , 7-12
Development of a chromatographic method for the determination of saquinavir in plasma samples of HIV patients
- 12 December 2001
- Published by Wiley in Biomedical Chromatography
- Vol. 16 (1) , 7-12
Development of a chromatographic method for the determination of saquinavir in plasma samples of HIV patients
- 1 November 2001
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 763 (1-2) , 21-33
Improved selectivity in detection of polar basic drugs by liquid chromatography–electrospray ionization mass spectrometry
- 1 November 2001
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 763 (1-2) , 21-33
Improved selectivity in detection of polar basic drugs by liquid chromatography–electrospray ionization mass spectrometry
- 1 December 2000
- Published by Springer Nature in Chromatographia
- Vol. 52 (11) , 827-830
Rapid determination of intramacrophagic amphotericin B by direct injection HPLC
- 1 December 2000
- Published by Springer Nature in Chromatographia
- Vol. 52 (11) , 827-830
Rapid determination of intramacrophagic amphotericin B by direct injection HPLC
- 17 June 1999
- Published by Wiley in Biomedical Chromatography
- Vol. 13 (4) , 272-275
Rapid high-performance liquid chromatographic determination of cefepime in human plasma
- 17 June 1999
- Published by Wiley in Biomedical Chromatography
- Vol. 13 (4) , 272-275
Rapid high-performance liquid chromatographic determination of cefepime in human plasma